Geneos Wealth Management Inc. - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$4,223
-30.6%
7500.0%0.00%
Q2 2023$6,083
+15.5%
7500.0%0.00%
Q1 2023$5,265
-15.9%
7500.0%0.00%
Q4 2022$6,263
+25.3%
7500.0%0.00%
Q3 2022$5,000
-16.7%
7500.0%0.00%
Q2 2022$6,000
-25.0%
7500.0%0.00%
Q1 2022$8,0007500.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q4 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$3,253,6286.54%
VILLERE ST DENIS J & CO LLC 300,173$1,671,9630.14%
PINNACLE ASSOCIATES LTD 478,309$2,664,1810.05%
BENJAMIN F. EDWARDS & COMPANY, INC. 45,050$2540.01%
FNY Investment Advisers, LLC 1,539$80.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,140$130,2780.00%
BROWN ADVISORY INC 74,836$416,8370.00%
Geneos Wealth Management Inc. 750$4,2230.00%
Focused Wealth Management, Inc 242$1,3480.00%
UBS Group AG 5,690$31,6930.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders